European Industry Pledges Support On Biosimilar Competition Action
Medicines For Europe Will Aid Local Regulatory Efforts
Executive Summary
Adrian van den Hoven, director general of Medicines for Europe, gives Generics Bulletin the industry’s viewpoint on recent action taken on barriers to biosimilar competition in Belgium, France and the Netherlands.